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Organic chemistry can contribute to the innovation 
through the design and synthesis of molecules those are 
valuable to human society. Our methodology possesses 
advantage in heteroatom chemistry, transition metal-
catalyzed reactions, and asymmetric synthesis. As for the 
synthetic procedure, we take note to develop atom-
economic as well as environment-benign reactions. We 
recognize the importance of the collaboration with various 
fields of technology of industry and academia. Recent 
examples of our projects include design, synthesis, and 
evaluation of aromatic compounds used in light-emitting 
field-effect transistors, sugar-fullerene linked compounds 
used in photodynamic therapy of cancers, and gadolinium 
complex of chiral dendrimers used in magnetic resonance 
imaging of cancers (shown in the figure).
 Scope of Research
Topics
43ICR ANNUAL REPORT, 2012
Synthesis and Functional Evaluation of 
Chiral Dendrimer-Triamine-Coordinated Gd 
Complexes as Highly Sensitive MRI Contrast 
Agents
MRI constitutes a prominent non-invasive imaging 
technique for disease diagnosis. Low-molecular-weight 
contrast agents based on Gd-DTPA (DTPA = diethylene- 
triaminepentaacetic acid) has been approved by the U.S. 
Food and Drug Administration (FDA) and the European 
Medicines Agency (EMEA), and is widely used in the 
clinical diagnosis of tumors. However, the non-specificity, 
low contrast efficiency and rapid renal excretion of this 
low-molecular-weight contrast agent necessitate a high 
dosage (ca. 0.5 M), which imposes a great physical strain 
on the patient. The main reason for the low contrast effi-
ciency is that, among the 9 coordination sites of Gd, up to 
8 are solidly occupied with ionic chelating ligands, and 
thus only 1 remains for coordination with free water 
molecules , which is observed by MRI. In addition, the 
rotational motion of Gd metal in the center of existing 
small ligands cannot be suppressed, and as a result the 
image contrast is considerably reduced.
In order to overcome these difficulties, we prepared 
chiral dendrimer-triamine-coordinated Gd complexes 
1-(R) and 1-(S) shown in Figure 1. Complexes 1-(R) and 
1-(S) have a triamine ligand and three chloride ligands, 
which stably occupy 6 coordination sites of Gd. Accord-
ingly, 3 coordination sites remain vacant for coordination 
with water molecules, which will be observed by MRI. 
In addition, large dendrimer in the periphery of Gd will 
suppress the molecular tumbling and rotation of Gd to 
result in the increase of the image contrast.
The ability as the imaging agents in vitro was evaluated 
by the longitudinal relaxivities (r1) of Gd complexes 
(1-(R) and 1-(S)), GdCl3·6H2O, and Gd-DTPA (Figure 2). 
As expected, the r1 values of 1-(R) and 1-(S) were 11.4 
and 11.1 mM–1 s–1, respectively, which are approximately 
3 times higher than that of Gd-DTPA (r1 = 4.6 mM–1 s–1).
Contrast enhancement by 1-(R) and 1-(S) was also 
evaluated in vivo. Figure 3 shows T1-weighted MR images 
of mice before and after intravenous injection of 1-(R), 
1-(S), and Gd-DTPA (0.10 mmol Gd/kg). Since most of 
the injected Gd-DTPA was excreted through the kidney, 
and accumulated in the bladder within 30 min, little 
 contrast enhancement was observed except for the kidney. 
In contrast, no accumulation of 1-(R) or 1-(S) in specific 
organs, such as the liver and kidney, was observed with 
high and prolonged contrast enhancement throughout the 
entire bodies of mice. They also showed improved vascu-
lar retention and a moderate renal excretion rate (com-
pletely excreted after 24 h).
In order to discuss the differences between optical 
isomers, the time-course of the signal intensities (SI) at 
the blood vessels in MR images was measured to indicate 
that the rate of clearance of 1-(R) was faster than that of 
1-(S) (Figure 4). In addition, the concentrations of Gd3+ in 
the blood and urine, 60 minutes after the injection of 1-(R) 
and 1-(S), were quantified by an atomic absorption spec-
troscopy, which showed that 30.2% of 1-(R) and 20.6% of 
1-(S) were transferred to urine, while 22.9% of 1-(R) and 
27.8% of 1-(S) were retained in the blood, respectively. All 
results obtained strongly support that 1-(S) is retained in 
vasculature for longer than 1-(R) after administration in a 
mouse body.Figure 1. Structure of chiral dendrimer-triamine-coordinated Gd 
 compleses, 1-(R) and 1-(S).
Figure 2. T1-weighted MR images of Gd-DTPA, GdCl36H2O, 1-(R), 
1-(S) (0.50 mM) and water.
Figure 3. T1-weighted MR images before 
and after intravenous injection of Gd-
DTPA (top), 1-(R) (middle), and 1-(S)
(bottom).
Figure 4. Time-course of the signal 
intensities (SI) at the blood vessels in 
MR images after injection of 1-(R) 
(circular symbol) and 1-(S) (triangular 
symbol).
